Y
Yusuke Shimakawa
Researcher at Pasteur Institute
Publications - 110
Citations - 2374
Yusuke Shimakawa is an academic researcher from Pasteur Institute. The author has contributed to research in topics: Hepatitis B virus & Hepatitis B. The author has an hindex of 20, co-authored 78 publications receiving 1639 citations. Previous affiliations of Yusuke Shimakawa include Hiroshima University & Conservatoire national des arts et métiers.
Papers
More filters
Journal ArticleDOI
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Graham S Cooke,Isabelle Andrieux-Meyer,Tanya L. Applegate,Rifat Atun,Jessica R Burry,Hugo Cheinquer,G.M. Dusheiko,Jordan J. Feld,Charles Gore,Max Griswold,Saeed Hamid,Margaret Hellard,Jinlin Hou,J. Howell,Jidong Jia,Natalia Kravchenko,Jeffrey V. Lazarus,Maud Lemoine,Olufunmilayo A. Lesi,Liudmyla Maistat,Brian J. McMahon,Homie Razavi,Teri Roberts,Bryony Simmons,Mark W. Sonderup,C Wendy Spearman,Bridie E Taylor,David L. Thomas,Imam Waked,John W. Ward,Stefan Wiktor,Ayman Abdo,Rakesh Aggarwal,Alessio Aghemo,Bandar Al-Judaibi,Mamun Al Mahtab,Arshad Altaf,Zyaad Ameen,Tarik Asselah,Oidov Baatarkkhuu,Ella Barber,Eleanor Barnes,Pascale Boulet,Louise Burrows,Maia Butsashvili,Erica Chan,Chelsea Chow,Ben Cowie,Chris Cunningham,Alexandre de Araujo,Graciela Diap,G.J. Dore,Joseph Doyle,Manal Elsayed,Emmanuel Fajardo,Edward Gane,Aneley Getahun,David J. Goldberg,Tiffany Got,Matthew Hickman,Andrew F. Hill,Sharon J. Hutchinson,Christopher R. Jones,Saleem Kamili,Amreen Khan,Alice Lee,Tin Yan Lee,Jioiji Malani,Tammy Meyers Morris,Shevanthi Nayagam,Richard Njouom,Ponsiano Ocama,Alisa Pedrana,Rosanna W. Peeling,Amulya Reddy,Jilian A. Sacks,Shiv Kumar Sarin,Yusuke Shimakawa,Marcela Silva,Pavlo Skala,Simon D. Taylor-Robinson,Alexander J. Thompson,Mark Thursz,Alfred Tonganibeia,Jack Wallace,James Ward,Fernando Herz Wolff,Peter Vickerman,Johnny Yau +88 more
TL;DR: Key recommendations include a greater focus on national progress towards elimination with support given, if necessary, through innovative financing measures to ensure elimination programmes are fully funded by 2020.
Journal ArticleDOI
The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa
Maud Lemoine,Maud Lemoine,Yusuke Shimakawa,Yusuke Shimakawa,Shevanthi Nayagam,Mustapha Khalil,Penda Suso,Jo Lloyd,Robert D. Goldin,Harr-Freeya Njai,Gibril Ndow,Makie Taal,Graham S Cooke,Umberto D'Alessandro,Muriel Vray,Papa Saliou Mbaye,Ramou Njie,Vincent Mallet,Mark Thursz +18 more
TL;DR: The GPR is a more accurate routine laboratory marker than APRI and Fib-4 to stage liver fibrosis in patients with CHB in West Africa and represents a simple and inexpensive alternative to liver biopsy and Fibroscan in sub-Saharan Africa.
Journal ArticleDOI
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study
Maud Lemoine,Maud Lemoine,Yusuke Shimakawa,Yusuke Shimakawa,Ramou Njie,Makie Taal,Gibril Ndow,Gibril Ndow,Isabelle Chemin,Saunab Ghosh,Harr Freeya Njai,Adam Jeng,Amina Sow,Coumba Toure-Kane,Souleymane Mboup,Penda Suso,Saydiba Tamba,Abdullah Jatta,Louise Sarr,Aboubacar Kambi,William Stanger,Shevanthi Nayagam,Jessica Howell,Liliane Mpabanzi,Liliane Mpabanzi,Liliane Mpabanzi,Ousman Nyan,Tumani Corrah,Hilton Whittle,Simon D. Taylor-Robinson,Umberto D'Alessandro,Maimuna Mendy,Mark Thursz +32 more
TL;DR: The high coverage of community-based screening, good linkage into care, and the small proportion of HBsAg carriers who need treatment suggest that large-scale screening and treatment programmes are feasible in sub-Saharan Africa.
Journal ArticleDOI
Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia
Yusuke Shimakawa,Maud Lemoine,Maud Lemoine,Harr Freeya Njai,Christian Bottomley,Gibril Ndow,Gibril Ndow,Robert D. Goldin,Abdoulie Jatta,A. Jeng-Barry,Rita Wegmüller,Sophie E. Moore,Ignatius Baldeh,Makie Taal,Umberto D'Alessandro,Umberto D'Alessandro,Hilton Whittle,Ramou Njie,Ramou Njie,Mark Thursz,Maimuna Mendy +20 more
TL;DR: The incidence of HCC among chronic HBV carriers in West Africa was higher than that in Europe but lower than rates in East Asia, which underlines the importance of interrupting perinatal transmission in sub-Saharan Africa.
Journal ArticleDOI
Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa.
TL;DR: The risk of mother‐to‐child transmission of hepatitis B virus (HBV) has been quoted as 70–90% among women positive for hepatitis B surface antigen (HBsAg) and e antigen (HBeAg), and 5–30% among HBsAg‐positive HBeAg‐negative women.